Evidence map›Paper›PMID 37231059›Full record

ArticleCancer gene therapy2023

Extracellular vesicles released by glioma cells are decorated by Annexin A2 allowing for cellular uptake via heparan sulfate.

Yu-Xi Song, Xin Li, Sheng-Dan Nie, Zhong-Xu Hu, Di Zhou, Ding-Ya Sun, Gao-Ya Zhou, Ying Wang, Jia-Jia Liu, Tao Song and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cancer gene therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Regulation of autophagy by non-coding RNAs in human glioblastoma.Medical oncology (Northwood, London, England) · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yu-Xi Song *Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, China.
Xin Li *Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, China. tengyunxin2010@163.com.
Sheng-Dan NieInstitute of Clinical Medicine, Hunan provincial people's hospital, the first affiliated hospital of Hunan Normal University, Changsha, China.
Zhong-Xu HuDepartment of Neurosurgery, Xiang-Ya Hospital, Central South University, Changsha, China.
Di ZhouDepartment of Pharmaceutical Engineering, College of Chemistry and Chemical Engineering, Central South University, Changsha, China.
Ding-Ya SunDepartment of Pharmaceutical Engineering, College of Chemistry and Chemical Engineering, Central South University, Changsha, China.
Gao-Ya ZhouDepartment of Neurology, Brain hospital of Hunan Province, Changsha, China.
Ying WangDepartment of Pathology, School of Basic Medical Science, Central South University, Changsha, China.
Jia-Jia LiuDepartment of Pharmaceutical Engineering, College of Chemistry and Chemical Engineering, Central South University, Changsha, China.
Tao SongDepartment of Neurosurgery, Xiang-Ya Hospital, Central South University, Changsha, China. songtaocsuws@163.com.
Shan WangDepartment of Pharmaceutical Engineering, College of Chemistry and Chemical Engineering, Central South University, Changsha, China. wangshancsu0717@163.com.ORCID 0000-0002-1402-1051
Central South University · CNHunan Institute of Mental Health · CNHunan Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs) play a crucial role in regulating cell behavior by delivering their cargo to target cells. However, the mechanisms underlying EV-cell interactions are not well understood. Previous studies have shown that heparan sulfate (HS) on target cell surfaces can act as receptors for exosomes uptake, but the ligand for HS on EVs has not been identified. In this study, we isolated EVs from glioma cell lines and glioma patients and identified Annexin A2 (AnxA2) on EVs as a key HS-binding ligand and mediator of EV-cell interactions. Our findings suggest that HS plays a dual role in EV-cell interactions, where HS on EVs captures AnxA2, and on target cells, it acts as a receptor for AnxA2. Removal of HS from the EV surface inhibits EV-target cell interaction by releasing AnxA2. Furthermore, we found that AnxA2-mediated binding of EVs to vascular endothelial cells promotes angiogenesis, and that antibody against AnxA2 inhibited the ability of glioma-derived EVs to stimulate angiogenesis by reducing the uptake of EVs. Our study also suggests that the AnxA2-HS interaction may accelerate the glioma-derived EVs-mediated angiogenesis and that combining AnxA2 on glioma cells with HS on endothelial cells may effectively improve the prognosis evaluation of glioma patients.

Indexed as

Annexin A2Extracellular VesiclesGliomaEndothelial CellsHeparan SulfateHumansLigandsAnnexin A2Heparan SulfateLigands

Identifiers

PMID37231059
OpenAlexW4378222661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.